posttransplant lymphoproliferative disease
Recently Published Documents


TOTAL DOCUMENTS

145
(FIVE YEARS 11)

H-INDEX

36
(FIVE YEARS 1)

Medicine ◽  
2021 ◽  
Vol 100 (6) ◽  
pp. e24713
Author(s):  
Rupan Gao ◽  
Yue Zhang ◽  
Gong Chen ◽  
Abhijeet Kumar Bhekharee ◽  
Zunguo Du ◽  
...  

2020 ◽  
Vol 18 (6) ◽  
pp. 741-743
Author(s):  
William H. Kitchens ◽  
David L. Jaye ◽  
Joel P. Wedd ◽  
Joseph F. Magliocca

2020 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
David M. Burns ◽  
Katherine Clesham ◽  
Yan A. Hodgson ◽  
Lynsey Fredrick ◽  
Joanna Haughton ◽  
...  

2019 ◽  
Vol 9 (2) ◽  
pp. e20-e20
Author(s):  
Paulette Cutruzzula Dreher ◽  
Jessica M. Fazendin ◽  
Kelly Lurz ◽  
Daniel C. Edwards ◽  
Stephen Guy ◽  
...  

Introduction: There exist few reports of de novo tumors involving an allograft kidney, and to the best of our knowledge there are only two previous reports of angiomyxoma Case Presentation: A 53-year-old Caucasian male with end-stage renal disease (ESRD) on hemodialysis (HD) secondary to malakoplakia with three failed prior renal transplants presented for repeat transplant evaluation. Imaging demonstrated a mass of the transplanted kidney suggestive of posttransplant lymphoproliferative disease (PTLPD). A biopsy was obtained revealing a predominance of myxoid material. The patient became increasingly symptomatic from the mass and underwent a palliative right transplant nephrectomy. Final pathology revealed angiomyxoid tumor. Conclusions: Angiomyxomas are asymptomatic, appear as PTLD on imaging and should be considered in the differential diagnosis of masses occurring in renal transplant allografts.


2019 ◽  
Vol 4 (5) ◽  
pp. 749-755 ◽  
Author(s):  
Andreas Kousios ◽  
Rowland Storey ◽  
Ethan Troy-Barnes ◽  
Mohamad Hamady ◽  
Emma Salisbury ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document